Meimei Han

Dr. Meimei Han


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2022 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
LLLi Li
Li Li
YGYanlin Gao
Yanlin Gao
WCWei Chen
Wei Chen
MHMeimei Han
Meimei Han
Purpose: To analyze the incidence and severity of retinopathy of prematurity (ROP) in north China, and to evaluate the effectiveness of different ROP screening criteria. Patients and methods: The screening data of premature infants were collected from 2016 to 2021. The severity of ROP was graded according to the International Classification of Retinopathy of Prematurity (2005). And the treatment for ROP followed the Early Treatment for Retinopathy of Prematurity Cooperative Group. The effects of gestational age (GA) and birth weight (BW) on the incidence and severity of ROP were evaluated. The screening data were also analyzed using different ROP screening guidelines. Results: A total of 4069 infants underwent ROP screening, and 728 infants (17.9%) were diagnosed with ROP. Of those, 78 infants (1.9%) received treatments. Gestational age and BW showed significant differences between infants with and without ROP (29.1 ± 2.1w vs. 32.9 ± 2.6w, p < 0.001; 1362.7 ± 427.3 g vs. 1751.9 ± 509.4 g, p < 0.001; respectively). Fifty-six infants (7.69%), 188 infants (25.82%), and 104 infants (14.29%) in all infants with ROP would have been missed according to the China, USA, and UK screening guidelines respectively. If GA ≤ 33 weeks and/or BW ≤ 2100 g were considered as screening criteria, only one infant (0.14%) with critical systemic illness was missed diagnosed with severe ROP. Conclusion: Gestational age and BW are major risk factors for the incidence and severity of ROP. And the incidence and treatment rate of ROP in Tianjin is similar to that reported in the other regions of China. Modified ROP screening criteria were considered to be more effective in Tianjin.

29 March 2018 in Oncology Letters
Verified
Journal Article
Open access
PDF file
LLLi Li
Li Li
WCWei Chen
Wei Chen
YWYuchuan Wang
Yuchuan Wang
LTLuosheng Tang
Luosheng Tang
MHMeimei Han
Meimei Han
Retinoblastoma is the most common type of intraocular pediatric malignant tumor, which typically affects children <6 years of age. However, the underlying molecular mechanisms of retinoblastoma progression remain unclear. The aim of the present study was to investigate the function of long non‑coding RNA (lncRNA) H19 in retinoblastoma clinical samples and cell lines, using reverse transcription‑quantitative polymerase chain reaction, western blotting, colony formation, MTT, fluorescence activated cell sorting, cell invasion and migration, and in vivo growth assays. The results demonstrated that H19 may serve a critical oncogenic function in the progression of retinoblastoma, as lncRNA H19 levels were markedly increased in retinoblastoma cells and tissues compared with corresponding controls. In addition, patients with retinoblastoma with increased lncRNA H19 expression experienced poorer survival time compared with those with decreased lncRNA H19 levels. Knockdown of lncRNA H19 significantly suppressed retinoblastoma cell proliferation, migration and invasion in vitro and in vivo. Furthermore, lncRNA H19 expression was also associated with multiple proteins, including cyclin‑dependent kinase 1, B‑cell lymphoma‑associated X protein, apoptosis regulator, tumor protein p53, vimentin, cadherin 13 and matrix metallopeptidase 9. In conclusion, lncRNA H19 may serve an important function in tumorigenesis and may be a potential target for therapy and prognosis in retinoblastoma.

4 June 2025 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
LLLi Li
Li Li
YGYanlin Gao
Yanlin Gao
YLYuhan Lu
Yuhan Lu
WCWei Chen
Wei Chen
MHMeimei Han
Meimei Han
Purpose: To evaluate the effectiveness and applicability of the postnatal growth and retinopathy of prematurity (G-ROP) screening criteria in a Chinese neonatal cohort.Methods: Data pertaining to the retinal screening of premature infants admitted to the neonatal intensive care unit from January 2021 through December 2021 were retrospectively analyzed. The severity of ROP was graded on the basis of the International Classification of Retinopathy of Prematurity criteria established in 2005. Treatment decisions for ROP were guided by the recommendations of the Early Treatment for Retinopathy of Prematurity Cooperative Group. The presence of six key variables that comprise the G-ROP screening criteria were carefully documented. The sensitivity and specificity of the G-ROP predictive algorithm in identifying infants with ROP requiring treatment were calculated.Results: A total of 352 infants with complete records were included in this study, among whom 120 infants (34.1%) were diagnosed with ROP. Of those, 21 infants (6.0%) received treatment. By applying the 6 criteria of the G-ROP model, all infants with severe ROP were successfully identified. The sensitivity of the G-ROP model in predicting treatment-requiring ROP was 100% (CI, 0.808–1.00), and the specificity was 47.8% (CI, 0.413–0.545). By applying the G-ROP criteria, the number of infants who required ROP screening would have been reduced by 122 (34.7%), while the number of screenings (1967) would have been reduced by 537 (27.3%).Conclusion: The prevalence of ROP (34.1%) and treatment-requiring ROP (6.0%) were relatively high in our cohort. Application of the G-ROP prediction model can improve the sensitivity and specificity of ROP screening. All infants with treatment-requiring ROP were correctly identified. The G-ROP screening criteria seemed to be effective and appropriate for predicting ROP in infants living in Tianjin, China.